Xenon Pharmaceuticals Inc.

NasdaqGM:XENE Stock Report

Market Cap: US$3.1b

Xenon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:XENE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Mar 24BuyUS$12,155Robin SherringtonIndividual1,234US$9.85
07 Mar 24SellUS$231,513Steven GannonIndividual5,000US$46.30
07 Mar 24SellUS$601,615Steven GannonIndividual13,000US$46.45
07 Mar 24SellUS$446,789Steven GannonIndividual13,000US$34.50
14 Dec 23SellUS$311,898Gary PatouIndividual7,598US$41.05
24 Aug 23SellUS$967,500Dawn SvoronosIndividual25,000US$38.70
31 May 23SellUS$1,916,032Simon PimstoneIndividual49,006US$39.90

Insider Trading Volume

Insider Buying: XENE insiders have sold more shares than they have bought in the past 3 months.


Ownership Breakdown

What is the ownership structure of XENE?
Owner TypeNumber of SharesOwnership Percentage
Private Companies102,6890.136%
Individual Insiders203,7000.27%
General Public1,306,9251.73%
Hedge Funds5,666,6667.51%
Institutions68,152,50290.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.7%.


Top Shareholders

Top 25 shareholders own 71.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.51%
Avoro Capital Advisors LLC
5,666,666US$234.0m15.7%3.32%
7.5%
FMR LLC
5,655,922US$233.6m33%0.02%
6.81%
Capital Research and Management Company
5,137,220US$212.2m8.8%0.01%
5.76%
Driehaus Capital Management LLC
4,345,180US$179.5m-3.72%1.36%
5.52%
Wellington Management Group LLP
4,162,654US$171.9m141%0.03%
4.07%
Polar Capital Holdings Plc
3,066,628US$126.7m2.09%0.53%
2.87%
Commodore Capital LP
2,167,793US$89.5m17.5%6.08%
2.82%
Paradigm Biocapital Advisors LP
2,127,400US$87.9m42.6%4.27%
2.74%
BlackRock, Inc.
2,067,063US$85.4m108%no data
2.7%
Pictet Asset Management Limited
2,040,400US$84.3m5.24%0.06%
2.18%
Braidwell LP
1,647,311US$68.0m-21.7%5.08%
2.18%
First Light Asset Management, LLC
1,645,490US$68.0m173%6.13%
2.09%
AllianceBernstein L.P.
1,574,568US$65.0m45.2%0.02%
2.03%
Marshall Wace LLP
1,528,648US$63.1m-29.1%0.13%
1.68%
Citadel Advisors LLC
1,266,844US$52.3m75.1%0.05%
1.66%
Rock Springs Capital Management LP
1,255,577US$51.9m6.59%1.44%
1.46%
Perceptive Advisors LLC
1,100,748US$45.5m78.3%1.02%
1.39%
Adage Capital Management, L.P.
1,048,725US$43.3m90.7%0.08%
1.32%
Baker Bros. Advisors LP
993,679US$41.0m32.2%0.52%
1.28%
Janus Henderson Group plc
966,065US$39.9m153%0.02%
1.18%
T. Rowe Price Group, Inc.
891,149US$36.8m127,000%no data
1.18%
BVF Partners L.P.
890,072US$36.8m-51.3%0.88%
1.16%
Point72 Asset Management, L.P.
875,065US$36.1m-22.3%0.08%
1.08%
Avidity Partners Management, L.P.
815,993US$33.7m154%1.27%
1.05%
TimesSquare Capital Management, LLC
793,954US$32.8m34.4%0.44%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.